^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CKD-702

    i
    Other names: CKD-702, CKD 702
    Company:
    Chong Kun Dang
    Drug class:
    c-MET inhibitor, EGFR antagonist
    Related drugs:
    1year
    CKD-702 Plus Irinotecan in Gastric Cancer (clinicaltrials.gov)
    P2, N=40, Recruiting, National Cancer Center, Korea
    New P2 trial
    |
    EGFR (Epidermal growth factor receptor)
    |
    EGFR overexpression • MET overexpression
    |
    irinotecan • CKD-702